Navigation Links
News from the Battlefield of Metastatic Cancer: Epeius,Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G),from the Stone of Chemistry and Physics

turing more than 40 histological plates, from surgical biopsies and excised tumors, the paper provides indisputable proofs-of-principle for both tumor destruction and active immunization induced by the targeted gene transfer approach.

The literary allegory of Le Morte du Tumour and the characterization of metastatic cancer as a personal battlefield is apt, for in the words of Dr. Frederick L. Hall, President and CEO of Epeius -- "In each and every cancer patient extends their very own impedimenta, which deepens and exacerbates with time and ineffectual apothecary. The scientists and physicians at Epeius Biotechnologies are proud to have participated in the historic events that brought these first targeted genetic medicines safely and conscientiously across the threshold of history, bringing hard science gently to the bedside."

About Epeius Biotechnologies

Epeius Biotechnologies Corporation is a privately held biopharmaceutical company dedicated to the advancement of genetic medicine with the development and commercialization of its proprietary targeted delivery systems. Credited with innovations ranging from oncogene discovery, to designer therapeutic genes, to pathotropic (disease-seeking) targeting, to high-performance vector engineering, to advanced biopharmaceutical manufacturing and bioprocess development, Epeius Biotechnologies is well positioned to "launch" its enabling platform technologies for the benefit of cancer patients worldwide. Rapid advances in clinical drug development provide Epeius with a unique opportunity for early revenues from the exportation and sale of its lead product to the Philippines and reciprocating Southeast Asian countries -- thus demonstrating the high growth potential of a small biotechnology company while maintaining the lowered risk profile of a biopharmaceutical company with a high-value, late-stage product.

To learn more about Rexin-G and Epeius'
'"/>




Page: 1 2 3

Related medicine technology :

1. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
2. Synta Presents Results for STA-4783 in Metastatic Melanoma Showing Improvement in Overall Survival
3. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
4. Caelyx Delays Time to Disease Progression as Maintenance Therapy in Patients with Metastatic Breast Cancer
5. Merck at ASCO 2007: New Data Demonstrate the Value of UFT as an Important Treatment Option for Patients With Metastatic Colorectal Cancer
6. Eloxatin (oxaliplatin injection)-Based Chemotherapy Sets New Treatment Benchmark in Patients With Metastatic Colorectal Cancer
7. Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO
8. Pharmacyclics Announces Promising Results From Phase 2 Clinical Trial of Xcytrin in Recurrent, Metastatic Non-Small Cell Lung Cancer
9. Positive Final Data from HyCAMP Phase II Trial in Metastatic Colorectal
10. Final Vectibix Positive Pivotal Phase 3 Trial Results In Metastatic Colorectal Cancer Patients Published
11. OncoGenex Technologies Announces Phase II Data of OGX-011 in Metastatic Breast Cancer at American Association for Cancer Research 2007 Annual Meeting
Post Your Comments:
(Date:6/18/2013)... Ill. , June 18, 2013 /PRNewswire-iReach/ -- ... its new X3130 Appliance Inlet Module. The X3130, ... breaker , combines a C14 appliance inlet module, ... compact package.  This three-in-one device allows design engineers ... designs - cutting installation time by 66 percent ...
(Date:6/18/2013)... , June 18, 2013  It has become ... Alliance Seating and Mobility, a subsidiary company of ... timely repair. This appears to be due to ... of field service employees.  (Logo: ... many of these clients are complex mobility users ...
(Date:6/18/2013)...  Recent regulatory and budget challenges have made it ... large pharmaceutical companies to effectively educate doctors and other ... their new products. With the pressure to reduce budgets ... these "Med Ed" groups find practical, economical ... the changes that are transforming the Medical Education area ...
Breaking Medicine Technology:Three-in-One X3130 Appliance Inlet Module 2Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints 2
... HistoRx, Inc. (privately held), a diagnostics company, announced ... of clinical diagnostic assays based on AQUA® technology. ... specialized laboratory service provider, is launching NexCourse®(1) BCa ... assays based on quantitative immunohistochemistry.  NexCourse BCa by ...
... SHANGHAI, Nov. 12, 2010 /PRNewswire-Asia/ -- WuXi PharmaTech ... announced shareholder resolutions adopted at its annual general ... November 10, 2010. (Logo: http://photos.prnewswire.com/prnh/20040705/CNM002LOGO) ... the meeting, WuXi PharmaTech shareholders approved the re-election ...
Cached Medicine Technology:HistoRx Announces First Clinical Diagnostic Use of AQUA® Technology 2HistoRx Announces First Clinical Diagnostic Use of AQUA® Technology 3WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2010 Annual General Meeting 2
(Date:6/19/2013)... (PRWEB) June 19, 2013 Kansas City will host ... Main Street Day . A section of Main Street in ... during the afternoon of the event. The Main Street Corridor ... event, which will help Kansas City join the ranks of dozens ... as a tool to foster community vibrancy and active lifestyles. , ...
(Date:6/19/2013)... June 19, 2013 Amerinet, Inc, ... ARAMARK Healthcare Technologies to help Pacific Medical Centers ... savings of more than 17 percent over the ... expenditures. , “Driving economies of scale and process ... management challenges facing multi-site providers,” said Shawn Padilla, ...
(Date:6/19/2013)... New data, published today in Menopause International ... experiencing less sex, and less satisfying sex compared ... they are considerably less likely to access appropriate ... atrophy1. , The first-of-its-kind study, called the CLarifying ... study, showed that British post-menopausal women with vaginal ...
(Date:6/19/2013)... derived from a naturally occurring compound (apocynin), has ... with Parkinson,s Disease symptoms by preventing deficits in ... the May 28, 2013 edition of ... postdoctoral fellow at the Medical College of Wisconsin ... Balaraman Kalyanaraman, Ph.D., Harry R. & Angeline ...
(Date:6/19/2013)... MA (PRWEB) June 19, 2013 ... , a premier kids entertainment media organization, and ... serious games company, will be introducing the Games ... StudenTopia. The 3D game is geared toward students ... eating and active lifestyles by rewarding positive choices. ...
Breaking Medicine News(10 mins):Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 2Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 3Health News:Amerinet Partners with ARAMARK Healthcare Technologies to Help Pacific Medical Centers Save 17 Percent and Better Manage System-Wide Equipment Program 2Health News:British women 50 percent less likley to recieve treatment for common menopausal symptoms 2Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 2Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 3Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 4Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 5
... DaVita Inc., a,leading provider of kidney care services ... kidney failure, is honored to receive the eHealthcare,Leadership ... the,Consumer/Disease-Focused category. DaVita.com was one of 1,100 entries,submitted ... program,recognizes websites in the healthcare industry such as ...
... BRIDGEWATER, N.J., Dec. 8 R&J Public Relations, a ... retained to engage in public relations initiatives to promote ... MAQUET is a leading global provider of medical ... technologies. , , ...
... Water is a critical ingredient in the manufacturing process ... quality water (HQW) is the single biggest driver for ... in the pharmaceutical sector. Frost & Sullivan,s European Environment ... wastewater management market in the European pharmaceutical industry has ...
... Cleveland Clinic,s Department of Orthopaedic Surgery, available for download as a PDF, ... ... (PRWEB) December 8, 2008 -- In 2008, 240,000 people in the United ... not inevitable. A new guide from Cleveland Clinic includes a multitude ...
... has joined the staff at the St. John-Clark Pain ... St. John, Randall Clark, Tracy Alan Jones, Brunella Lucchi ... rest of the clinic,s dream team. From chicago, ... recruiting top therapists from across the country who specialize ...
... , ... West Chester, PA (PRWEB) December 5, 2008-- ... of its Precious Metal tubing production capacity due to increasing demand ... metals - Platinum, in particular - are characterized by a high ...
Cached Medicine News:Health News:DaVita.com Receives eHealthcare Leadership Award 2Health News:R&J Public Relations Selected to Promote MAQUET Inc.'s VARIOP Operating Room Suite in North America 2Health News:Pharmaceutical Water Markets, the Economic Crunch Creates New Opportunities in Southern and Eastern Europe 2Health News:Cleveland Clinic Issues New Guide for Chronic Hip Pain 2Health News:Cleveland Clinic Issues New Guide for Chronic Hip Pain 3Health News:The St. John-Clark Pain Treatment Center Forms Manual Therapy 'Dream Team' 2Health News:Johnson Matthey Medical Announces Expansion 2
... insulin pen with a memory. HumaPen MEMOIR records the ... (including priming doses). You can see exactly when and ... you simply "dial" your dose by turning the dose ... initial set-up. If you dial too many units, you ...
Assay development using client's antibodies and antigens to meet diagnostic target...
Colloidal Gold Conjugated, Streptavidin - 50 OD...
Colloidal Gold Conjugated, Goat anti-rabbit IgG (H&L) - 50 OD...
Medicine Products: